MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: Status report

European Journal of Radiology

Volumn 34, Issue 3, 2000, Pages 148-155

  Brasch, Robert ^a   Turetschek, Karl ^a,b  

^a Department of Radiology   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Macromolecular microvascular permeability; MR imaging; MRI contrast media; Vascular endothelial growth factor

Indexed keywords

ANTIBODIES; BIOASSAY; BIOMATERIALS; BLOOD VESSELS; DRUG PRODUCTS; DRUG THERAPY; ONCOLOGY; RADIOTHERAPY;

MACROMOLECULAR CONTRAST MEDIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR;

MAGNETIC RESONANCE IMAGING;

ANGIOGENIC FACTOR; CONTRAST MEDIUM; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER GRADING; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS;

CAPILLARY PERMEABILITY; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0033860453     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(00)00195-9     Document Type: Article

References (29)

1. Folkman J. What is evidence that tumors are angiogenesis dependent? J. Nat. Cancer. Inst. 82:1989;4-6.
2. Liotta L.A., Kleinerman J., Saidel G.M. Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res. 34:1974;997-1004.
3. Jain R., Gerlowski L. Extravascular transport in normal and tumor tissues. Crit. Rev. Oncol/Hematol. 5:1984;115-170.
4. Fidler I., Ellis L. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
5. Weidner N. Intratumoral microvascular density as a prognostic factor in cancer. Am. J. Pathol. 147:1995;9-19.
6. Folkman J. Introduction: angiogenesis and cancer. Semin. Cancer Biol. 3:1992;47-48.
7. Dvorak H., Brown L., Detman M., Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am. J. Pathol. 146:1995;1029-1039.
8. Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31:1986;288-305.
9. Jain R. Transport of molecules across tumor vasculator. Cancer Met. Rev. 6:1987;559-593.
10. Jain R. Barriers to drug delivery in solid tumors. Sci. Am. 271:1994;58-65.
11. Heywang-Köbrunner S. Contrast-enhanced magnetic resonance imaging of the breast. Invest. Radiol. 29:1994;94-104.
12. Weinmann, H.-J., 1985, Personal Communication.
13. Daldrup H., Shames D., Wendland M. et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small molecular contrast media. Am. J. Roentgen. 171:1998;941-949.
14. Roberts, T., Schwickert, H., Brasch, R., 1995. Quantitative estimation of contrast agent tissue accumulation: potential errors, Soc. Magn. Reson. Proc., Nice, France. 1129.
15. Helbich, T., Roberts, T., Gossmann, A. et al. Quantitative gadopentetate-enhanced MR imaging of breast tumors: testing of different analytical methods, Magn Res Med (in press).
16. Kaiser W., Reisner M. False positive cases in dynamic MR mammography. 1992;934 RSNA, Chicago.
17. Dvorak H., Nagy J., Dvorak J., Dvorak A. Identification and characterisation of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133:1988;95-109.
18. Ostrowitzki S., Fick J., Roberts T. et al. Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterisation in an intracranial glioma model. JMRI. 8:1998;799-806.
19. Roberts H., Saeed M., Roberts T. et al, Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for mesurements of normal and abnormal microvascular permeability. JMRI. 7:1997;331-338.
20. Su M.-Y., Wang Z., Carpenter P., Lao X., Muhler A., Nalcioglu O. Characterisation of N-ethyl-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J. Magn. Res. Imaging. 9:1999;177-286.
21. Adam G., Mühler A., Spuntrup E. et al. Differentiation of spontaneous canine brest tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA polymer, a new blood-pool agent. Invest. Radiol. 31:1996;267-274.
22. Turetschek, K., Huber, S. et al., 1999. Comparison of soluble and particulate macromolecular contrast media for tumor microvascular characterisation and correlations with tumor grade, International Contrast Medium Research '99. Woodstock, VT.
23. vanDijke C., Brasch R., Roberts T. et al., Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterisations of tumor microvascular and histologic capillary density. Radiology. 198:1996;813-818.
24. Pham C., Roberts T., vanBruggen N. et al. Magnetic resonance imaging detects supression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest. 6:1998;224-230.
25. Brasch R., Pham C., Shames D. et al. Assessing angiogenesis using macromolecular MRI contrast media. JMRI. 7:1997;68-74.
26. Heuser L., Miller F. Differential macromolecular leakage from the vasculature of tumors. Cancer. 57:1986;461-464.
27. Aicher K.P., Dupon J.W., White D. et al. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res. 50:1990;7376-7381.
28. Cohen F., Kuwatsura R., Shames D. et al. Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following X-irradiation. Invest. Radiol. 29:1995;970-977.
29. Weidner N., Semple J., Welch W., Folman J. Tumor angiogenesis and metasasis-correlation in invasive breast carcinoma. New Engl. J. Med. 324:1991;1-8.